The angiotensin-endothelin relationship: does it play a role in cardiovascular and renal pathophysiology?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Hypertension

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.HJH.0000098171.36890.E2PMID 14654742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension

  2003cited by this paper
• Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress

  2002cited by this paper
• Endothelin-Converting Enzyme Inhibition Ameliorates Angiotensin II–Induced Cardiac Damage

  2002cited by this paper
• Role of endothelin-1 in hypertension and vascular disease.

  2001cited by this paper
• ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats

  2001cited by this paper
• Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.

  2000cited by this paper
• Endothelin system-dependent cardiac remodeling in renovascular hypertension.

  1999cited by this paper
• Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats.

  1998cited by this paper
• ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension

  1998cited by this paper
• ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.

  1998cited by this paper
• Effect of chronic ETA‐selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

  1997cited by this paper
• Role for endothelin-1 in angiotensin II-mediated hypertension.

  1997cited by this paper
• Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.

  1997cited by this paper
• Understanding the nature of renal disease progression.

  1997cited by this paper
• Enhanced expression of endothelin‐1 gene in resistance arteries in severe human essential hypertension

  1997cited by this paper
• Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.

  1997cited by this paper
• Progression of proteinuric diabetic and nondiabetic renal diseases: a possible role for renal endothelin.

  1997cited by this paper
• Vascular and cardiac overexpression of endothelin‐1 gene in one‐kidney, one clip Goldblatt hypertensive rats but only in the late phase of two‐kidney one clip Goldblatt hypertension

  1996cited by this paper
• Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.

  1996cited by this paper
• Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.

  1995cited by this paper
• Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

  1994cited by this paper
• A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression.

  1993cited by this paper
• Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.

  1993cited by this paper
• Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

  1993cited by this paper
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.

  1992cited by this paper
• Hypertension and Cardiovascular Disease in Transgenic (mren2)27 Rats via Blockade of Angiotensin Ii Type 1 Receptor and Not of Endothelin Receptor Prevents

  year unknowncited by this paper

• Blocking of interleukin-1 suppresses angiotensin II-induced renal injury.

  2021cites this paper
• Endothelin in nondiabetic chronic kidney disease: preclinical and clinical studies.

  2015cites this paper
• Pathophysiology of Hypertension

  2015cites this paper
• Interleukin 6 Underlies Angiotensin II–Induced Hypertension and Chronic Renal Damage

  2012cites this paper
• The Endothelin System

  2012cites this paper
• Development and Validation of a Rat Model for Examining the AT1 and ETA Receptor-Blocking Activity of Dual AT1 and ETA Receptor Blockers

  2009cites this paper
• Peptides vasoactifs endogènes dans la prolifération accrue des cellules musculaires lisses vasculaires de rats spontanément hypertendus: rôle des facteurs de croissance

  2009cites this paper
• CHAPTER 15 – Kinins and Endothelin

  2008cites this paper
• Endothelin-receptor antagonists in arterial hypertension: Further indications?

  2007cites this paper
• Characteristics of neural and humoral systems involved in the regulation of blood pressure in snakes.

  2007cites this paper
• Inhibition of the renin angiotensin system: Implications for the endothelium

  2006cites this paper
• Vascular endothelin in hypertension.

  2005cites this paper
• Effects of systemic endothelin A receptor antagonism in various vascular beds in men: In vivo interactions of the major blood pressure–regulating systems and associations with the GNB3 C825T polymorphism

  2004cites this paper
• St John's wort, depression, and catecholamines

  2004cites this paper